Key result
Ascending aortic surgery was associated with increased all-cause mortality compared to matched controls (32.3% vs 13.8%; HR 2.77; 95% CI 1.91-4.01).
Why the study?
Surgery of ascending aortic aneurysms is performed prophylactically or acutely, but expected survival after surgery remains uncertain.
Does surgery of the ascending aorta impact long-term survival compared to matched controls?
Cohort (n=559)
No
Does surgery of the ascending aorta impact long-term survival compared to matched controls?
Hazard Ratio: 2.77 (95% CI 1.91–4.01)
Absolute Event Rate: 32.3% vs 13.8%
Patients undergoing ascending aortic surgery have a higher short- and long-term mortality compared to matched controls, with 40% of deaths in the surgical group attributed to aortic disease.
May warrant caution in surgical thresholds for ascending aorta; leaves open causality versus confounding in observational data.
OBJECTIVES: Surgery of ascending aortic aneurysms is performed prophylactically or acute. The expected survival after surgery is uncertain. The goal of this study was to compare mortality in people with aortic surgery with matched controls. METHODS: All patients undergoing ascending aortic surgery at Umeå University Hospital from 1988 to 2012, who previously participated in 1 of 3 population-based health surveys, were matched to 2 randomly selected controls from the same health survey and followed until death or until censoring on 24 August 2017, whichever came first. Mortality was calculated using the Kaplan-Meier method and the log-rank test. Cox regression analyses were made for all-cause mortality, adjusted for traditional cardiovascular risk factors. Deaths during the first 90 days after surgery and at >90 days postoperatively were studied separately. RESULTS: The median follow-up time was 9.2 years. A total of 61 of 189 patients and 51 of 370 controls died [hazard ratio (HR) 2.77, 95% confidence interval (CI) 1.91-4.01]. Mortality was increased during the first 90 days post-surgery (HR 43.4, 95% CI 5.83-323), as well as after the first 90 days (HR 1.90, 95% CI 1.25-2.88) and after acute surgery (HR 6.05, 95% CI 2.92-12.56) as well as after elective surgery (HR 2.10, 95% CI 1.35-3.27). Among 57 surgical patients with information about cause of death, 23 (40%) died of aortic disease. CONCLUSIONS: During follow-up, more patients died than matched controls. Findings were consistent when adjusting for traditional cardiovascular risk factors and across subgroups. Both short-term and long-term postoperative deaths were increased as well.
No takes yet. Share an insight, caveat, or question.
Larsson et al. (2022) conducted a cohort in Ascending aortic aneurysms (n=559). Ascending aortic surgery vs. Matched controls was evaluated on All-cause mortality (HR 2.77, 95% CI 1.91-4.01). Ascending aortic surgery was associated with increased all-cause mortality compared to matched controls (32.3% vs 13.8%; HR 2.77; 95% CI 1.91-4.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: